XSNX (Novaccess Global) Ending Cash Position: $0.02 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSNX Novaccess Global Inc XSNX
12 GF Score
Price $0.00
View Full Analysis

What is Novaccess Global Ending Cash Position?

Novaccess Global XSNX 12 Ending Cash Position is $0.02 Mil as of Sep. 2024. GuruFocus rates XSNX with a GF Score™ of 12/100.

Novaccess Global's Ending Cash Position for the quarter that ended in Sep. 2024 was $0.02 Mil.

Novaccess Global's quarterly Ending Cash Position declined from Mar. 2024 ($0.01 Mil) to Jun. 2024 ($0.00 Mil) but then increased from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.02 Mil).

Novaccess Global's annual Ending Cash Position declined from Sep. 2022 ($0.06 Mil) to Sep. 2023 ($0.02 Mil) and declined from Sep. 2023 ($0.02 Mil) to Sep. 2024 ($0.02 Mil).

Novaccess Global Ending Cash Position Related Terms

Novaccess Global Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Novaccess Global's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novaccess Global Ending Cash Position Chart

Novaccess Global Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.18 0.06 0.02 0.02

Novaccess Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.01 0.00 0.02
XSNX
12GF Score
Novaccess Global Inc XSNX
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novaccess Global Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Novaccess Global's Ending Cash Position for the fiscal year that ended in Sep. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.021415+-0.000524
=0.02

Novaccess Global's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.000794+0.020097
=0.02

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.02 Mil mean?
Novaccess Global (XSNX) has a Ending Cash Position of $0.02 Mil as of Sep. 2024. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Novaccess Global and its competitors.
Is Novaccess Global's Ending Cash Position too high?
Novaccess Global's current Ending Cash Position is $0.02 Mil. Overall, Novaccess Global has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novaccess Global's Ending Cash Position compare to NBIO and BTAX?
Novaccess Global's Ending Cash Position of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Novaccess Global and its competitors. Novaccess Global's current Ending Cash Position is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novaccess Global stock overvalued right now?
Novaccess Global (XSNX) has a current Ending Cash Position of $0.02 Mil. The current Ending Cash Position is $0.02 Mil. Novaccess Global's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Novaccess Global (XSNX), the current Ending Cash Position is $0.02 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novaccess Global Business Description

Address 459 Columbus Avenue, No. 607, New York, NY, USA, 10024
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
12GF Score

Get the complete analysis for XSNX

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price